| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |